Overall quality of life improves to similar levels after mechanical circulatory support regardless of severity of heart failure before implantation

被引:58
作者
Grady, Kathleen L. [1 ]
Naftel, David [2 ]
Stevenson, Lynne [3 ]
Dew, Mary Amanda [4 ,5 ,6 ,7 ]
Weidner, Gerdi [8 ]
Pagani, Francis D. [9 ]
Kirklin, James K. [2 ]
Myers, Susan [2 ]
Baldwin, Timothy [10 ]
Young, James [11 ]
机构
[1] Northwestern Univ, Div Cardiac Surg, Dept Surg, Chicago, IL 60611 USA
[2] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA
[3] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA
[4] Univ Pittsburgh, Sch Med, Dept Epidemiol, Pittsburgh, PA USA
[5] Univ Pittsburgh, Sch Med, Dept Biostat, Pittsburgh, PA USA
[6] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA
[7] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[8] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA
[9] Univ Michigan, Ctr Circulatory Support, Ann Arbor, MI 48109 USA
[10] NHLBI, Bethesda, MD 20892 USA
[11] Cleveland Clin Fdn, Cleveland, OH 44195 USA
关键词
mechanical circulatory support; health-related quality of life; heart failure; INTERMACS; continuous-flow pump; VENTRICULAR ASSIST DEVICE; INTERMACS ANNUAL-REPORT; DESTINATION THERAPY; HEALTH-STATUS; EQ-5D; OUTCOMES; SURVIVAL; IMPACT;
D O I
10.1016/j.healun.2013.10.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: The severity of pre-implantation heart failure may affect post-implantation health-related quality of life (HRQOL). The purpose of our study was to examine differences in HRQOL from before mechanical circulatory support (MCS) through 1 year after surgery by Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) patient profiles. METHODS: Data from 1,559 adults with advanced heart failure who received primary continuous-flow pumps between June 23, 2006, and March 31, 2010, and were enrolled in INTERMACS were analyzed. IARQOL data were collected using the EQ-5D-3L survey before implantation and at 3, 6, and 12 months after implantation. Statistical analyses included chi-square and t-tests, using all available data for each time period. Paired t-tests and sensitivity analyses were also conducted. RESULTS: HRQOL was poor before MCS implantation among patients with INTERMACS profiles 1 to 7 and significantly improved after MCS implantation for all profiles. Stratified by INTERMACS profile, problems within each of the 5 dimensions of HRQOL (i.e., mobility, self-care, usual activities, pain, and anxiety/depression) generally decreased from before to after implantation. By 6 months after implantation, patients with all INTERMACS profiles reported similar frequencies of problems for all HRQOL dimensions. Paired t-tests and sensitivity analyses supported almost all of our findings. CONCLUSIONS: HRQOL is poor among advanced heart failure patients with INTERMACS profiles 1 to 7 before MCS implantation and improves to similar levels for patients who remained on MCS 1 year after surgery. Patients have problems in HRQOL dimensions before and after MCS; however, the frequency of reporting problems decreases for all dimensions within most profiles across time. (C) 2014 International Society for Heart and Lung Tiansplantation. All rights reserved.
引用
收藏
页码:412 / 421
页数:10
相关论文
共 28 条
  • [1] Decision Making in Advanced Heart Failure A Scientific Statement From the American Heart Association
    Allen, Larry A.
    Stevenson, Lynne W.
    Grady, Kathleen L.
    Goldstein, Nathan E.
    Matlock, Daniel D.
    Arnold, Robert M.
    Cook, Nancy R.
    Felker, G. Michael
    Francis, Gary S.
    Hauptman, Paul J.
    Havranek, Edward P.
    Krumholz, Harlan M.
    Mancini, Donna
    Riegel, Barbara
    Spertus, John A.
    [J]. CIRCULATION, 2012, 125 (15) : 1928 - 1952
  • [2] Study on health-related quality of life in patients with advanced heart failure before and after transplantation
    Almenar-Pertejo, M.
    Almenar, L.
    Martinez-Dolz, L.
    Campos, J.
    Galan, J.
    Girones, P.
    Ortega, F.
    Ortega, T.
    Rebollo, P.
    Salvador, A.
    [J]. TRANSPLANTATION PROCEEDINGS, 2006, 38 (08) : 2524 - 2526
  • [3] NHLBI's Program for VAD Therapy for Moderately Advanced Heart Failure: The REVIVE-IT Pilot Trial
    Baldwin, J. Timothy
    Mann, Douglas L.
    [J]. JOURNAL OF CARDIAC FAILURE, 2010, 16 (11) : 855 - 858
  • [4] Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification
    Boyle, Andrew J.
    Ascheim, Deborah D.
    Russo, Mark J.
    Kormos, Robert L.
    John, Ranjit
    Naka, Yoshifumi
    Gelijns, Annetine C.
    Hong, Kimberly N.
    Teuteberg, Jeffrey J.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04) : 402 - 407
  • [5] Braunwald Eugene., 2005, Braunwald's Heart disease, Text book Cardiovascular Medicine Disease, V7th Edn
  • [6] The impact of chronic heart failure on health-related quality of life data acquired in the baseline phase of the CARE-HF study
    Calvert, MJ
    Freemantle, N
    Cleland, JGF
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2005, 7 (02) : 243 - 251
  • [7] A review of health utilities using the EQ-5D in studies of cardiovascular disease
    Dyer, Matthew T. D.
    Goldsmith, Kimberley A.
    Sharples, Linda S.
    Buxton, Martin J.
    [J]. HEALTH AND QUALITY OF LIFE OUTCOMES, 2010, 8
  • [8] Field M.J., 1997, Approaching death: Improving care at the end of life
  • [9] Grady K L, 1998, Am J Crit Care, V7, P106
  • [10] Longitudinal change in quality of life and impact on survival after left ventricular assist device implantation
    Grady, KL
    Meyer, PM
    Dressler, D
    Mattea, A
    Chillcott, S
    Loo, A
    White-Williams, C
    Todd, B
    Ormaza, S
    Kaan, A
    Costanzo, MR
    Piccione, W
    [J]. ANNALS OF THORACIC SURGERY, 2004, 77 (04) : 1321 - 1327